HSIC
48
3
NWSA
71
-4
EXR
33
2
PG
46
3
FMC
20
-2
EMN
42
2
PRU
50
3
MKC
51
-2
D
37
2
PAYX
54
9
IVZ
50
2
CNP
52
-2
TGNA
53
3
KSS
42
3
IFF
45
-2
AES
49
-2
ICE
57
2
CVS
32
3
BK
65
2
MPC
33
2
HSIC
48
3
NWSA
71
-4
EXR
33
2
PG
46
3
FMC
20
-2
EMN
42
2
PRU
50
3
MKC
51
-2
D
37
2
PAYX
54
9
IVZ
50
2
CNP
52
-2
TGNA
53
3
KSS
42
3
IFF
45
-2
AES
49
-2
ICE
57
2
CVS
32
3
BK
65
2
MPC
33
2
Financhill
Back

Sino Biopharmaceutical 10K Form

Sell
45

SBMFF
Sino Biopharmaceutical

Last Price:
$0.41
Seasonality Move:
11.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SBMFF News And Ratings

See the #1 stock for the next 7 days that we like better than SBMFF

SBMFF Financial Statistics

Sales & Book Value

Annual Sales: $3.7B
Cash Flow: $0
Price / Cash Flow: 10.7
Annual Sales: $0.25
Price / Book: 1.66

Profitability

EPS (TTM): 0.01700
Net Income (TTM): $568.6M
Gross Margin: $3B
Return on Equity: 10.53%
Return on Assets: 6.27%

Sino Biopharmaceutical Earnings Forecast

Key Sino Biopharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 25 years for SBMFF is 80.95%.
  • The Selling, General & Administrative Expenses for SBMFF have been equal to 42.24% of Gross Profit Margin.
  • The Research & Development expenses have been 16.81% of Revenue.
  • The Interest Expense is 21.24% of Operating Income.
  • The Net Earning history of SBMFF is 8.90% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 16 years.

Sino Biopharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SBMFF
Website: sinobiopharm.com

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 1.15
Quick Ratio: 1.07

Price-to-Earnings

Trailing P/E Ratio: 23.11
Forward P/E Ratio: 0

SBMFF Technical Analysis vs Fundamental Analysis

Sell
45
Sino Biopharmaceutical (SBMFF) is a Sell

Is Sino Biopharmaceutical a Buy or a Sell?